by | May 12, 2026 | Cui, Jianmin
— Published date: 5/13/2026
Value Proposition: Non-invasive stimulation strategy that can deliver dynamic glycemic control to treat Type 1 diabetes.
Technology Description
Researchers at Washington University in St. Louis have developed Acoustic-Controlled Insulin Secretion (ACIS), a novel sono…
by | May 12, 2026 | Chen, Hong, Cui, Jianmin
— Published date: 5/13/2026
Value Proposition: Non-invasive stimulation strategy that can deliver dynamic glycemic control to treat Type 1 diabetes.
Technology Description
Researchers at Washington University in St. Louis have developed Acoustic-Controlled Insulin Secretion (ACIS), a novel sono…
by | Mar 5, 2026 | Millman, Jeffrey, Zayed, Mohamed
— Published Date: 6/12/2025
Value Proposition: Novel vascular graft device that delivers whole pancreatic islets to enhance glycemic control and chronic management of diabetes, without the need for immunosuppression.
Technology Description
Researchers at Washington University in St. Louis have de…
by | Feb 5, 2026 | Connor, Michelle, Leuthardt, Eric, Osbun, Joshua, Siripoksup, Piyarat, Zayed, Mohamed
— Published date: 2/6/2026
Value Proposition: Device designed to stimulate neural structures to increase weight loss in people affected by obesity.
Technology Description
Researchers at Washington University in St. Louis are developing an endovascular stimulation device that can be implanted i…
by | Jan 13, 2026 | Brestoff Parker, Jonathan, Diamond, Michael, Jia, Wentong
— Published date: 1/14/2026
Value Proposition: Novel target for therapeutic treatment of obesity and related metabolic diseases.
Technology Description
Researchers at Washington University in St. Louis have developed a therapeutic targeting MXRA8 to treat obesity and associated metabolic disea…